Elorac has launched Zithranol-RR (anthralin rapid release microcrystalline encapsulated cream, 1.2%) for the treatment of mild to moderate plaque psoriasis. Zithranol-RR is available by prescription in a 45gm tube.
Zithranol-RR’s advanced delivery of anthralin is designed to rapidly release anthralin to the psoriatic skin reducing the risk of staining and irritation seen with traditional formulations of anthralin.
Joel Bernstein, dermatologist and CEO of Elorac, said: “The key to Zithranol-RR is the advanced delivery system designed to rapidly release anthralin allowing for excellent efficacy with only once daily application. Zithranol-RR makes it easy to utilize the known efficacy and safety of anthralin while minimizing the challenges commonly seen with traditional anthralin formulations.”